TITLE

MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases

AUTHOR(S)

Zhen-wei PAN; Yan-jie LU; Bao-feng YANG

PUB. DATE

January 2010

SOURCE

Acta Pharmacologica Sinica;Jan2010, Vol. 31 Issue 1, p1

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Currently, cardiovascular diseases remain one of the leading causes of morbidity and mortality in the world, indicating the need for innovative therapies and diagnosis for heart disease. MicroRNAs (miRNAs) have recently emerged as one of the central players in regulating gene expression. Numerous studies have documented the implications of miRNAs in nearly every pathological process of the cardiovascular system, including cardiac arrhythmia, cardiac hypertrophy, heart failure, cardiac fibrosis, cardiac ischemia and vascular atherosclerosis. More surprisingly, forced expression or suppression of a single miRNA is enough to cause or alleviate the pathological alteration, underscoring the therapeutic potential of miRNAs in cardiovascular diseases. In this review we summarize the key miRNAs that can solely modulate the cardiovascular pathological process and discuss the mechanisms by which they exert their function and the perspective of these miRNAs as novel therapeutic targets and/or diagnostic markers. In addition, current approaches for manipulating the action of miRNAs will be introduced.

ACCESSION #

47265436

Tags: RNA;  HEART -- Diseases;  DRUG targeting;  GENE expression;  CARDIOVASCULAR system -- Diseases

 

Related Articles

• MicroRNA Regulation in Cardiovascular Disease. Da Costa Martins, P. A.; Leptidis, S.; Salic, K.; De Windt, L.J. // Current Drug Targets;Aug2010, Vol. 11 Issue 8, p900 

  No abstract available.

• Circulating microRNAs: novel biomarkers for cardiovascular diseases. Xu, Jiahong; Zhao, Jiangmin; Evan, Graham; Xiao, Chunyang; Cheng, Yan; Xiao, Junjie // Journal of Molecular Medicine;Aug2012, Vol. 90 Issue 8, p865 

  MicroRNAs (miRNAs) are a novel class of small, non-coding, single-stranded RNAs that negatively regulate gene expression via translational inhibition or mRNA degradation followed by protein synthesis repression. Many miRNAs are expressed in a tissue- and/or cell-specific manner and their...

• Cardiovascular Dysfunction in Hypercholesterolemia Associated With Enhanced Formation of AT1-Receptor and of Eicosanoids. Schwemmer, Michael; Sommer, Olaf; Koeckerbauer, Reinhold; Bassenge, Eberhard // Journal of Cardiovascular Pharmacology & Therapeutics;Mar2000, Vol. 5 Issue 1, p59 

  The article analyzes cardiac angiotensin receptor expression and metabolism of altered signalling of angiotensin, eicosanoids, and nitric oxide in hypercholesterolemic animals. Results show that hypercholesterolemia was associated with fatty degeneration of the liver and profound myocardial and...

• Oxygen, oxidative stress, hypoxia, and heart failure. Giordano, Frank J. // Journal of Clinical Investigation;Mar2005, Vol. 115 Issue 3, p500 

  A constant supply of oxygen is indispensable for cardiac viability and function. However, the role of oxygen and oxygen-associated processes in the heart is complex, and they and can be either beneficial or contribute to cardiac dysfunction and death. As oxygen is a major determinant of cardiac...

• Cardiovascular.  // Modern Pathology;Jan2005 Supplement 1, Vol. 18, p57A 

  The article focuses on several studies on different diseases related to the cardiovascular system. There is a study on endomyocardial biopsies, using transmission electron microscopy. Ultrastructural evidence of intercalated disc remodeling in arrhythmogenic right ventricular cardiomyopathy was...

• The Transcriptome of Human Epicardial, Mediastinal and Subcutaneous Adipose Tissues in Men with Coronary Artery Disease. Guauque-Olarte, Sandra; Gaudreault, Nathalie; Piché, Marie-Ève; Fournier, Dominique; Mauriège, Pascale; Mathieu, Patrick; Bossé, Yohan // PLoS ONE;2011, Vol. 6 Issue 5, p1 

  Background: The biological functions of epicardial adipose tissue (EAT) remain largely unknown. However, the proximity of EAT to the coronary arteries suggests a role in the pathogenesis of coronary artery disease (CAD). The objectives of this study were to identify genes differentially...

• Silencing of FABP3 promotes apoptosis and induces mitochondrion impairment in embryonic carcinoma cells. Shen, Ya-Hui; Song, Gui-Xian; Liu, Yao-Qiu; Sun, Wei; Zhou, Li-Juan; Liu, Hai-Lang; Yang, Rong; Sheng, Yan-Hui; Qian, Ling-Mei; Kong, Xiang-Qing // Journal of Bioenergetics & Biomembranes;Jun2012, Vol. 44 Issue 3, p317 

  Fatty acid binding protein 3 (FABP3) (also known as H-FABP) is a member of the intracellular lipid-binding protein family, and is mainly expressed in cardiac muscle tissue. The in vivo function of FABP3 is proposed to be in fatty acid metabolism, trafficking, and cell signaling. Our previous...

• The Molecular Basis for the Pharmacological Activity of Anthocyans. Domitrovic, R. // Current Medicinal Chemistry;Oct2011, Vol. 18 Issue 29, p4454 

  This review summarizes the current knowledge of the regulatory role of pure anthocyans in cellular signaling pathways and gene expression. The molecular basis for anthocyans pharmacological activity includes the regulation of plethora of mechanisms mainly involved in: (1) suppression of the...

• Enhanced expression of salusin-β contributes to progression of atherosclerosis in LDL receptor deficient mice. Zhou, Cheng-Hua; Liu, Lan-Lan; Wu, Yu-Qing; Song, Zheng; Xing, Shu-Hua // Canadian Journal of Physiology & Pharmacology;Apr2012, Vol. 90 Issue 4, p463 

  Atherosclerosis is an important underlying pathology of cardiovascular diseases. The aim of this study was to observe the expression of salusin-β, a new vasoactive peptide, in vascular tissues of low-density lipoprotein receptor deficient (LDLR-/-) mice, and to evaluate the effect of salusin-β...

Read the Article